Cargando…

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge. The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lun, Shichun, Guo, Haidan, Onajole, Oluseye K., Pieroni, Marco, Gunosewoyo, Hendra, Chen, Gang, Tipparaju, Suresh K., Ammerman, Nicole C., Kozikowski, Alan P., Bishai, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909880/ https://www.ncbi.nlm.nih.gov/pubmed/24352433 http://dx.doi.org/10.1038/ncomms3907

Ejemplares similares

Advancing the Therapeutic Potential of Indoleamides for Tuberculosis
por: Lun, Shichun, et al.
Publicado: (2019)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis
por: Parthasarathy, Geetha, et al.
Publicado: (2012)

Design, synthesis and evaluation of novel indole-2-carboxamides for growth inhibition of Mycobacterium tuberculosis and paediatric brain tumour cells
por: Alsayed, Shahinda S. R., et al.
Publicado: (2021)

Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport
por: Viljoen, Albertus, et al.
Publicado: (2017)

Alterations in Phospholipid Catabolism in Mycobacterium Tuberculosis LysX Mutant
por: Maloney, Erin, et al.
Publicado: (2011)

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
por: Maiga, Mamoudou, et al.
Publicado: (2012)

Synthetic Lethality Reveals Mechanisms of Mycobacterium tuberculosis Resistance to β-Lactams
por: Lun, Shichun, et al.
Publicado: (2014)

Design, synthesis, and biological evaluation of novel arylcarboxamide derivatives as anti-tubercular agents
por: Alsayed, Shahinda S. R., et al.
Publicado: (2020)

Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
por: Alsayed, Shahinda S. R., et al.
Publicado: (2023)

Design, Synthesis and Biological Evaluation of N-phenylindole Derivatives as Pks13 Inhibitors againstMycobacterium tuberculosis
por: Cai, Yanpeng, et al.
Publicado: (2022)

MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival
por: Bullen, C. Korin, et al.
Publicado: (2023)

Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments
por: Larsson, Christer, et al.
Publicado: (2012)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Aerosol Mycobacterium tuberculosis Infection Causes Rapid Loss of Diversity in Gut Microbiota
por: Winglee, Kathryn, et al.
Publicado: (2014)

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
por: Parveen, Sadiya, et al.
Publicado: (2023)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models
por: Converse, Paul J., et al.
Publicado: (2010)

The Two-Domain LysX Protein of Mycobacterium tuberculosis Is Required for Production of Lysinylated Phosphatidylglycerol and Resistance to Cationic Antimicrobial Peptides
por: Maloney, Erin, et al.
Publicado: (2009)

Role of Mycobacterium tuberculosis pknD in the Pathogenesis of central nervous system tuberculosis
por: Be, Nicholas A, et al.
Publicado: (2012)

N-(2-Hydroxyethyl)-N-(tricyclo[3.3.1.1(3,7)]dec-2-yl)benzamide
por: Boyle, Grant A., et al.
Publicado: (2008)

2-(Tricyclo[3.3.1.1(3,7)]dec-2-ylamino)ethanol hemihydrate
por: Boyle, Grant A., et al.
Publicado: (2008)

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models()()
por: Ugolkov, Andrey, et al.
Publicado: (2017)

N-(Adamantan-1-yl)-2-chloroacetamide
por: Onajole, Oluseye K., et al.
Publicado: (2011)

Essential Metabolites of Mycobacterium tuberculosis and Their Mimics
por: Lamichhane, Gyanu, et al.
Publicado: (2011)

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer
por: Suri, Amreena, et al.
Publicado: (2019)

The Mycobacterium tuberculosis genome at 25 years: lessons and lingering questions
por: Koleske, Benjamin N., et al.
Publicado: (2023)

Mycobacterium tuberculosis: A Pathogen That Can Hold Its Breath a Long Time
por: Shaku, Moagi T., et al.
Publicado: (2022)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice
por: Almeida, Deepak V., et al.
Publicado: (2014)

Erratum to “Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis” [EBioMedicine 2 (8), August 2015, 868–873]
por: Maiga, Mamoudou, et al.
Publicado: (2015)

Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice
por: Krug, Stefanie, et al.
Publicado: (2023)

1,7-Dimethylpentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane-8,11-dione
por: Chakka, Sai Kumar, et al.
Publicado: (2010)

Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota
por: Namasivayam, Sivaranjani, et al.
Publicado: (2020)

Expression of a Subset of Heat Stress Induced Genes of Mycobacterium tuberculosis Is Regulated by 3',5'-Cyclic AMP
por: Choudhary, Eira, et al.
Publicado: (2014)

283. Screening the PE/PPE secreted effectors of Mycobacterium tuberculosis to uncover novel virulence-promoting genes
por: Koleske, Benjamin, et al.
Publicado: (2023)

Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals
por: Davis, Stephanie L., et al.
Publicado: (2009)

Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
por: Choi, Seong Won, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lda8tg8sesj4n9hjtidlg83tfv